A single-arm, phase II open-label trial to investigate the efficacy and safety of intradermal injection of etanercept for remission induction in discoid lupus erythematosus (TARGET-DLE)

导出原文传递

翻译打印收藏纠错

作者： Yusof, M. Y. M. ^[1] ; Wittmann, M. ^[2] ; Fernandez, C. ^[3] ; Wilson, D. ^[4] ; Edward, S. ^[5] ; Abignano, G. ; Alase, A. ; Sharples, L. ; Laws, P. ; Goodfield, M. ; Vital, E. M. ; Emery, P.

作者单位： Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England ^[1] Leeds Teaching Hosp NHS Trust, Dept Histopathol, Leeds, W Yorkshire, England ^[2] Univ Leeds, Leeds Inst Clin Trials Res, Leeds, W Yorkshire, England ^[3] Leeds Teaching Hosp NHS Trust, NIHR Leeds Biomed Res Ctr, Leeds, W Yorkshire, England ^[4] Leeds Teaching Hosp NHS Trust, Dept Dermatol, Leeds, W Yorkshire, England ^[5]

发布时间 2020-04-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

British Journal of Dermatology

2019年180卷6期

E191-E192页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A single-arm, phase II open-label trial to investigate the efficacy and safety of intradermal injection of etanercept for remission induction in discoid lupus erythematosus (TARGET-DLE)

British Journal of Dermatology

相似文献

British Journal of Dermatology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A single-arm, phase II open-label trial to investigate the efficacy and safety of intradermal injection of etanercept for remission induction in discoid lupus erythematosus (TARGET-DLE)

British Journal of Dermatology

相似文献

British Journal of Dermatology

相关期刊

检索历史清除